Channel Therapeutics Corporation, a clinical-stage biotechnology company focused on non-opioid pain treatments, expressed encouragement regarding Vertex Pharmaceuticals' recent Phase 2 data for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback